» Articles » PMID: 39022748

Sustained Transmission over Two Decades of a Previously Unrecognised MPT64 Negative Strain in Queensland, Australia: a Whole Genome Sequencing Study

Overview
Date 2024 Jul 18
PMID 39022748
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MPT64 is a key protein used for (MTB) complex strain identification. We describe protracted transmission of an MPT64 negative MTB strain in Queensland, Australia, and explore genomic factors related to its successful spread.

Methods: All MPT64 negative strains identified between 2002 and 2022 by the Queensland Mycobacteria Reference Laboratory, and an additional 2 isolates from New South Wales (NSW), were whole genome sequenced. Bayesian modelling and phylogeographical analyses were used to assess their evolutionary history and transmission dynamics. Protein structural modelling to understand the putative functional effects of the mutated gene coding for MPT64 protein was performed.

Findings: Forty-three MPT64 negative isolates were sequenced, belonging to a single MTB cluster of Lineage 4.1.1.1 strains. Combined with a UK dataset of the same lineage, molecular dating estimated 1990 (95% HPD 1987-1993) as the likely time of strain introduction into Australia. Although the strain has spread over a wide geographic area and new cases linked to the cluster continue to arise, phylodynamic analysis suggest the outbreak peaked around 2003. All MPT64 negative strains had a frame shift mutation (delAT, p.Val216fs) within the MPT64 gene, which confers two major structural rearrangements at the C-terminus of the protein.

Interpretation: This study uncovered the origins of an MPT64 negative MTB outbreak in Australia, providing a richer understanding of its biology and transmission dynamics, as well as guidance for clinical diagnosis and public health action. The potential spread of MPT64 negative strains undermines the diagnostic utility of the MPT64 immunochromatographic test.

Funding: This study was funded from an operational budget provided to the Queensland Mycobacterium Reference Laboratory by Pathology Queensland, Queensland Department of Health.

Citing Articles

mutations in with negative MPT64 antigen assay results from a tertiary hospital in Southeastern China.

Pan X, Zhou S, Jin L, Ji S, Lou X, Lu B Front Med (Lausanne). 2025; 12:1531853.

PMID: 40078396 PMC: 11898740. DOI: 10.3389/fmed.2025.1531853.


Considering best practice standards for routine whole-genome sequencing for TB care and control.

Denholm J, de Vries G, Anthony R, Robinson E, Backx M, Laurenson I IJTLD Open. 2024; 1(10):431-436.

PMID: 39398433 PMC: 11467850. DOI: 10.5588/ijtldopen.24.0320.

References
1.
Ofori-Anyinam B, Kanuteh F, Agbla S, Adetifa I, Okoi C, Dolganov G . Impact of the Mycobaterium africanum West Africa 2 Lineage on TB Diagnostics in West Africa: Decreased Sensitivity of Rapid Identification Tests in The Gambia. PLoS Negl Trop Dis. 2016; 10(7):e0004801. PMC: 4936735. DOI: 10.1371/journal.pntd.0004801. View

2.
Denholm J, Behr M, de Vries G, Anthony R, Robinson E, Backx M . Developing best practice public health standards for whole genome sequencing of . Lancet Reg Health West Pac. 2024; 46:101014. PMC: 11143450. DOI: 10.1016/j.lanwpc.2024.101014. View

3.
Brent A, Mugo D, Musyimi R, Mutiso A, Morpeth S, Levin M . Performance of the MGIT TBc identification test and meta-analysis of MPT64 assays for identification of the Mycobacterium tuberculosis complex in liquid culture. J Clin Microbiol. 2011; 49(12):4343-6. PMC: 3232969. DOI: 10.1128/JCM.05995-11. View

4.
Bouckaert R, Vaughan T, Barido-Sottani J, Duchene S, Fourment M, Gavryushkina A . BEAST 2.5: An advanced software platform for Bayesian evolutionary analysis. PLoS Comput Biol. 2019; 15(4):e1006650. PMC: 6472827. DOI: 10.1371/journal.pcbi.1006650. View

5.
Eldholm V, Monteserin J, Rieux A, Lopez B, Sobkowiak B, Ritacco V . Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain. Nat Commun. 2015; 6:7119. PMC: 4432642. DOI: 10.1038/ncomms8119. View